We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · September 14, 2021

Early Changes in Serum Albumin Predict Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment

Inflammatory Bowel Diseases

 

Additional Info

Disclosure statements are available on the authors' profiles:

Inflammatory Bowel Diseases
Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment
Inflamm. Bowel Dis. 2021 Aug 19;27(9)1452-1461, SH Lee, M Walshe, EH Oh, SW Hwang, SH Park, DH Yang, JS Byeon, SJ Myung, SK Yang, T Greener, AV Weizman, MS Silverberg, BD Ye

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading